A VACCINE FOR ALL MANKIND: SPUTNIK V’S EFFICACY IN FIGHTING COVID-19 IS VALIDATED BY INTERNATIONALLY PEER REVIEWED DATA PUBLISHED IN THE LANCET

In an interim analysis of a Phase III clinical trial, Sputnik V showed strong efficacy, immunogenicity and safety results. Efficacy of Sputnik V against COVID-19 was reported at 91.6%. Analysis included data on 19,866 volunteers, who received 

Read More 

Advertisement Valentine Day Shopping, Jewellery and Clothes of First Ladies,  Lifestyle of the First Ladies,  Save 50.0% on select products from VANLAMS with promo code 50EAYVTV, through 1/31 while supplies last.